Gottfried Von Keudell, Md Phd

This study tests whether combining rituximab (an antibody) with venetoclax (a targeted pill) can effectively treat marginal zone lymphoma that hasn't been treated before. About 33 adults with measurable disease will receive the drug combo, and researchers will measure how many ac…

This study tests a drug called odronextamab in 35 adults with untreated, low-tumor follicular lymphoma. The goal is to see if the drug can shrink or eliminate tumors. Participants receive the drug as an infusion, and researchers will monitor how well it works and any side effects…

This study is testing whether an antibody drug called epcoritamab can help control Waldenstrom Macroglobulinemia, a rare blood cancer, in patients who have already received previous treatments. The trial will enroll 20 participants to measure how well their cancer responds to thi…